Literature DB >> 2505513

MR imaging in neurocysticercosis: a study of 56 cases.

H R Martinez1, R Rangel-Guerra, G Elizondo, J Gonzalez, L E Todd, J Ancer, S S Prakash.   

Abstract

We reviewed the MR findings in 56 patients with neurocysticercosis (NCC). MR findings were correlated with other neuroradiologic findings in 40 cases, with histopathologic studies in 15 surgically treated patients, and with autopsy findings in one case. Active NCC was characterized by the presence of a cyst in the brain parenchyma (53%) or in an intraventricular subependymal (22%) or subarachnoid (10%) location. The cysticercus appeared as a vesicle with a high-intensity signal nodule that corresponded to the scolex. Cyst mobility was observed in two intraventricular cases. Periventricular edema and ependymitis appeared as high-intensity signal on T2 sequences. Inactive NCC (15%) was characterized by calcifications (signal void on T1 and T2 sequences), aqueductal stenosis, and tissue thickness in the basal meninges. Degenerative cysticercus appeared on MR as an irregular vesicle without a scolex. Active NCC was better detected with MR than with CT (85% vs 21%), whereas inactive forms were observed better with CT (23% vs 14%). We conclude that MR is sensitive in the diagnosis of active NCC and may be useful in evaluating the degenerative changes in the parasite that occur as a result of natural degeneration, host response, or medical therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505513      PMCID: PMC8335268     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  26 in total

1.  Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequences.

Authors:  S S Govindappa; J P Narayanan; V M Krishnamoorthy; C H Shastry; A Balasubramaniam; S S Krishna
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  High-dose praziquantel with cimetidine for refractory neurocysticercosis: a case report with clinical and MRI follow-up.

Authors:  T Yee; J A Barakos; R T Knight
Journal:  West J Med       Date:  1999-02

3.  NEUROCYSTICERCOSIS - A CLINICOPATHOLOGICAL APPRAISAL.

Authors:  S Kudesia; Vani Santosh; Ily Pal; Sarala DAS; S K Shankar
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 4.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

5.  Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru.

Authors:  H H Garcia; R H Gilman; M Catacora; M Verastegui; A E Gonzalez; V C Tsang
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

6.  Comparative study of CT and MRI in patients with seizures and a solitary cerebral cysticercus granuloma.

Authors:  V Rajshekhar; M J Chandy
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

Review 7.  Neurocysticercosis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

Review 8.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

9.  Transventricular neuroendoscopic excision of giant racemose subarachnoid cysticercosis.

Authors:  Carmina F Angeles; Dennis Vollmer; Aaron Mohanty
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

10.  Diagnosis and treatment of neurocysticercosis.

Authors:  Christina M Coyle; Herbert B Tanowitz
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.